Literature DB >> 23482696

FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma.

Vasavi Paidpally1, Alin Chirindel, Stella Lam, Nishant Agrawal, Harry Quon, Rathan M Subramaniam.   

Abstract

This article discusses the value of 18F-fluoro-2-deoxyglucose PET/CT imaging biomarkers in head and neck squamous cell carcinoma. 18F-fluoro-2-deoxyglucose PET/CT is valuable at baseline staging, radiotherapy planning, therapy response assessment and in the follow-up of patients with head and neck squamous cell carcinoma. Maximum and peak standardized uptake value (SUVmax and SUVpeak), metabolic tumor volume and total lesion glycolysis are the common 18F-fluoro-2-deoxyglucose quantitative parameters that have been studied, along with qualitative assessments. These parameters will be evaluated with respect to their established or potential role as noninvasive biomarkers for patient risk stratification, treatment response and survival outcome.

Entities:  

Keywords:  FDG; PET/CT; head and neck squamous cell carcinoma; imaging biomarkers

Year:  2012        PMID： 23482696      PMCID： PMC3587845          DOI： 10.2217/iim.12.60

Source DB:  PubMed          Journal:  Imaging Med        ISSN： 1755-5191


  80 in total

1.  Usefulness of interim FDG-PET after induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck receiving sequential induction chemotherapy followed by concurrent chemoradiotherapy.

Authors:  Dok Hyun Yoon; Yoojin Cho; Sang Yoon Kim; Soon Yuhl Nam; Seung-Ho Choi; Jong-Lyel Roh; Sang-wook Lee; Si Yeol Song; Jeong Hyun Lee; Jae Seung Kim; Kyung-Ja Cho; Sung-Bae Kim
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-08-02       Impact factor: 7.038

2.  The role of positron emission tomography/CT imaging in head and neck cancer patients after radical chemoradiotherapy.

Authors:  J M Sherriff; B Ogunremi; S Colley; P Sanghera; A Hartley
Journal:  Br J Radiol       Date:  2012-06-27       Impact factor: 3.039

3.  Prognostic significance of 18F-FDG PET parameters and plasma Epstein-Barr virus DNA load in patients with nasopharyngeal carcinoma.

Authors:  Kai-Ping Chang; Ngan-Ming Tsang; Chun-Ta Liao; Cheng-Lung Hsu; Ming-Jui Chung; Chuan-Wei Lo; Sheng-Chieh Chan; Shu-Hang Ng; Hung-Ming Wang; Tzu-Chen Yen
Journal:  J Nucl Med       Date:  2012-01       Impact factor: 10.057

4.  Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer.

Authors:  Maria Hentschel; Steffen Appold; Andreas Schreiber; Nasreddin Abolmaali; Andrij Abramyuk; Wolfgang Dörr; Joerg Kotzerke; Michael Baumann; Klaus Zöphel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-02-25       Impact factor: 9.236

5.  Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer.

Authors:  H Minn; M Lapela; P J Klemi; R Grénman; S Leskinen; P Lindholm; J Bergman; E Eronen; M Haaparanta; H Joensuu
Journal:  J Nucl Med       Date:  1997-12       Impact factor: 10.057

6.  Use of 18F-FDG PET for primary treatment strategy in patients with squamous cell carcinoma of the oropharynx.

Authors:  Sang Yoon Kim; Jong-Lyel Roh; Mi Ra Kim; Jae Seung Kim; Seung-Ho Choi; Soon Yuhl Nam; Sang-wook Lee; Sung-Bae Kim
Journal:  J Nucl Med       Date:  2007-05       Impact factor: 10.057

7.  Nonsquamous cell malignant tumours of the oral cavity: an overview.

Authors:  Tom Daley; Mark Darling
Journal:  J Can Dent Assoc       Date:  2003-10       Impact factor: 1.316

8.  Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.

Authors:  Trang H La; Edith J Filion; Brit B Turnbull; Jackie N Chu; Percy Lee; Khoa Nguyen; Peter Maxim; Andy Quon; Edward E Graves; Billy W Loo; Quynh-Thu Le
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-14       Impact factor: 7.038

9.  Prognostic value of 18F-FDG PET/CT before and after radiotherapy for locally advanced nasopharyngeal carcinoma.

Authors:  P Xie; J-B Yue; Z Fu; R Feng; J-M Yu
Journal:  Ann Oncol       Date:  2009-11-13       Impact factor: 32.976

10.  FDG-PET. A possible prognostic factor in head and neck cancer.

Authors:  W Halfpenny; S F Hain; L Biassoni; M N Maisey; J A Sherman; M McGurk
Journal:  Br J Cancer       Date:  2002-02-12       Impact factor: 7.640
View more
  41 in total

Review 1.  Present and future role of FDG-PET/CT imaging in the management of head and neck carcinoma.

Authors:  Kazuhiro Kitajima; Yuko Suenaga; Kazuro Sugimura
Journal:  Jpn J Radiol       Date:  2015-10-27       Impact factor: 2.374

2.  Regulation of glycolysis in head and neck squamous cell carcinoma.

Authors:  Dhruv Kumar
Journal:  Postdoc J       Date:  2017-01

3.  Value of Intratumoral Metabolic Heterogeneity and Quantitative 18F-FDG PET/CT Parameters to Predict Prognosis in Patients With HPV-Positive Primary Oropharyngeal Squamous Cell Carcinoma.

Authors:  Esther Mena; Mehdi Taghipour; Sara Sheikhbahaei; Abhinav K Jha; Arman Rahmim; Lilja Solnes; Rathan M Subramaniam
Journal:  Clin Nucl Med       Date:  2017-05       Impact factor: 7.794

4.  Is There a Role for PET/CT Parameters to Characterize Benign, Malignant, and Metastatic Parotid Tumors?

Authors:  Ayse Tuba Karagulle Kendi; Kelly R Magliocca; Amanda Corey; James R Galt; Jeffrey Switchenko; J Trad Wadsworth; Mark W El-Deiry; David M Schuster; Nabil F Saba; Patricia A Hudgins
Journal:  AJR Am J Roentgenol       Date:  2016-06-08       Impact factor: 3.959

5.  Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.

Authors:  Ji Won Kim; Jungsu S Oh; Jong-Lyel Roh; Jae Seung Kim; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-06-12       Impact factor: 9.236

6.  18F-FDG-PET/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma, is visual analysis of PET and contrast enhanced CT better than the numbers?

Authors:  A Tuba Kendi; Amanda Corey; Kelly R Magliocca; Dana C Nickleach; James Galt; Jeffrey M Switchenko; Mark W El-Deiry; J Trad Wadsworth; Patricia A Hudgins; Nabil F Saba; David M Schuster
Journal:  Eur J Radiol       Date:  2015-03-14       Impact factor: 3.528

7.  Imaging modality utilization trends in patients with stage III-IV oropharyngeal squamous cell carcinoma.

Authors:  Yukako Ichimiya; Krishna Alluri; Charles Marcus; Simon Best; Christine H Chung; Rathan M Subramaniam
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-01-15

8.  Prognostic value of pre-treatment maximum standardized uptake value and CRP in radiotherapy of esophageal cancer.

Authors:  Haruka Jinnouchi; Hideomi Yamashita; Tomoki Kiritoshi; Yosuke Miki; Atsuto Katano; Keiichi Nakagawa; Osamu Abe
Journal:  Mol Clin Oncol       Date:  2021-05-25

Review 9.  Emerging biomarkers in head and neck cancer in the era of genomics.

Authors:  Hyunseok Kang; Ana Kiess; Christine H Chung
Journal:  Nat Rev Clin Oncol       Date:  2014-11-18       Impact factor: 66.675

10.  Impact of total lesion glycolysis measured by 18F-FDG-PET/CT on overall survival and distant metastasis in hypopharyngeal cancer.

Authors:  Hidenori Suzuki; Masami Nishio; Hayao Nakanishi; Nobuhiro Hanai; Hitoshi Hirakawa; Takeshi Kodaira; Tsuneo Tamaki; Yasuhisa Hasegawa
Journal:  Oncol Lett       Date:  2016-06-23       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.